Literature DB >> 7055187

Bendectin and fetal development. A study of Boston City Hospital.

S Morelock, R Hingson, H Kayne, E Dooling, B Zuckerman, N Day, J J Alpert, G Flowerdew.   

Abstract

As part of a prospective study investigating maternal characteristics and habits during pregnancy and their impact on fetal development, 1,690 mother/infant pairs were studied. Of the mothers, 375 reported using Bendectin during pregnancy. Multivariate analyses examining birth weight, length, head circumference, gestational age, and congenital malformations as dependent variables demonstrated no associations between Bendectin exposure and adverse fetal outcome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055187     DOI: 10.1016/s0002-9378(16)32338-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Antinauseants in pregnancy: teratogens or not?

Authors:  A Biringer
Journal:  Can Fam Physician       Date:  1984-10       Impact factor: 3.275

Review 2.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

3.  Bendectin: the wrong way to regulate drug availability.

Authors:  J S Leeder; S P Spielberg; S M MacLeod
Journal:  Can Med Assoc J       Date:  1983-11-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.